Skip to main page content
Access keys NCBI Homepage MyNCBI Homepage Main Content Main Navigation

Search Page

My NCBI Filters
Text availability
Article attribute
Article type
Publication date

Search Results

33 results
Filters applied: . Clear all Results are displayed in a computed author sort order. Results by year timeline is unavailable
Page 1
Death receptor agonists as a targeted therapy for cancer.
Wiezorek J, Holland P, Graves J. Wiezorek J, et al. Clin Cancer Res. 2010 Mar 15;16(6):1701-8. doi: 10.1158/1078-0432.CCR-09-1692. Epub 2010 Mar 2. Clin Cancer Res. 2010. PMID: 20197482 Review.
Apo2L/TRAIL and the death receptor 5 agonist antibody AMG 655 cooperate to promote receptor clustering and antitumor activity.
Graves JD, Kordich JJ, Huang TH, Piasecki J, Bush TL, Sullivan T, Foltz IN, Chang W, Douangpanya H, Dang T, O'Neill JW, Mallari R, Zhao X, Branstetter DG, Rossi JM, Long AM, Huang X, Holland PM. Graves JD, et al. Among authors: holland pm. Cancer Cell. 2014 Aug 11;26(2):177-89. doi: 10.1016/j.ccr.2014.04.028. Epub 2014 Jul 17. Cancer Cell. 2014. PMID: 25043603 Free article.
RIP4 regulates epidermal differentiation and cutaneous inflammation.
Rountree RB, Willis CR, Dinh H, Blumberg H, Bailey K, Dean C Jr, Peschon JJ, Holland PM. Rountree RB, et al. Among authors: holland pm. J Invest Dermatol. 2010 Jan;130(1):102-12. doi: 10.1038/jid.2009.223. J Invest Dermatol. 2010. PMID: 19626033
33 results